4 results
To determine the clinical value of chronic implantation of an electrode adjacent to the dorsal genital nerve for conditional electrical stimulation in patients with overactive bladder syndrome The aim is to have >60-70% decrease in number of…
* To assess the safety and tolerability of Ampligen administered intranasally in a dosing schedule for 13 days (7 doses) in healthy subjects.* To characterize the mucosal immune response following Ampligen administration over time.
To measure detection thresholds, loudness, and melody perception in CI recipients in order to assess extent of nerve degeneration between good and poor performers with respect to speech perception.
The primary objective of the safety run-in (phase Ib) is to determine the safety of combination therapy with durvalumab and rintatolimod. The primary objective of the phase II trial is to determine the clinical benefit rate of combination therapy…